The real-world effectiveness of intravenous brivaracetam as a second-line treatment in status epilepticus-Reference-Cited by-同舟云学术

The real-world effectiveness of intravenous brivaracetam as a second-line treatment in status epilepticus

Published:2023-11 Issue: Volume:148 Page:109464
ISSN:1525-5050
Container-title:Epilepsy & Behavior
language:en
Short-container-title:Epilepsy & Behavior

Author:

Martellino Chiara,Laganà Angelina,Atanasio Giorgia,Lamanna Fabio,Attardo Silvia,Cascino Simona,De Luca Marcella,Pardeo Orazio,Giacobbe Giuseppa,Tripepi Giovanni,Roberti Roberta,Granata Francesca,Morace Carmela,Russo Emilio,Labate Angelo^ORCID

Funder

Angelini Pharma

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Neurology (clinical),Neurology

Reference17 articles.

1. Epidemiology and outcomes of status epilepticus;Ascoli;Int J Gen Med,2021

2. A definition and classification of status epilepticus – report of the ILAE task force on classification of status epilepticus;Trinka;Epilepsia,2015

3. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American epilepsy society;Glauser;Epilepsy Curr,2016

4. Pharmacology of new and developing intravenous therapies for the management of seizures and epilepsy;Morano;Expert Opin Pharmacother,2019

5. Management of status epilepticus in patients with liver or kidney disease: a narrative review;Mastroianni;Expert Rev Neurother,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brivaracetam use in clinical practice: a Delphi consensus on its role as first add-on therapy in focal epilepsy and beyond;Neurological Sciences;2024-04-01